PER - Megathread, page-96

Hi Waynesworld and George1972
We all know that your Contribution on this thread re Science is great..
JG stated in PER asx announcement that DMD could generate $1 billion per annum..So let’s take out costs =
so we arrive @ $500 million per annum
X eps biotechs work on multiples of 15 to over 100
Eg Sarepta
I’m my opinion the bigger game for PER is the inflammation market
I mentioned in my previous post that only getting 10% of the inflammation market would earn us $10 billion per annum

So guys
Do you agree that the inflammation market will be our primary focus and big $$ earner ?